Skip to main content

Pubertät – Normalität, Normvarianten und Abweichungen

Störungen der Pubertätsentwicklung sicher erkennen

Puberty—norms, normal variants, and disorders

Identifying pathologies of pubertal development

Zusammenfassung

Weicht ein Mädchen in seiner Pubertätsentwicklung von der Peergroup ab, so kann dies zu erheblichem Leidensdruck führen. Nicht jede wahrgenommene Abweichung ist jedoch objektivierbar und nicht jede objektivierbare pathologisch. Neben Normvarianten können einer Pubertätstempostörung verschiedene, ganz unterschiedliche Erkrankungen zugrunde liegen. Die Ursachen reichen von „idiopathischen“ Störungen über endokrinologische, immunologische und genetische Erkrankungen, Tumoren bis hin zu psychosomatischen und psychiatrischen Krankheitsbildern. Im Beitrag wird die Abgrenzung einer möglichen Pathologie gegen die – sehr viel häufigeren – Normvarianten erläutert und die Differenzialdiagnosen der wichtigsten abklärungsbedürftigen, therapiepflichtigen Krankheitsbilder dargestellt.

Abstract

Deviation from the peer group in a girl’s pubertal development creates stress in the adolescent. However, not every subjectively perceived deviation is objectively manifest and not every proven deviation is associated with pathology. Besides variations of the norm, a large number of very different disorders can result in alteration of the onset and/or temporal course of pubertal development. These range from “idiopathic” disturbances, endocrinological and immunological diseases, genetic variations, and tumors, to psychosomatic and psychiatric diseases. In this article the emphasis is on distinguishing the more common and non-pathological variations of the norm from the various diseases that require further investigation and consequently treatment.

This is a preview of subscription content, access via your institution.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10
Abb. 11

Literatur

  1. 1.

    Eckert-Lind C et al (2020) Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis. JAMA Pediatr 174(4):e195881

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Bourguignon, Juul (2012) Pediatric and Adolescent Gynaecology. Karger, , S 13

    Google Scholar 

  3. 3.

    Aksglaede L et al (2009) Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 123(5):e932–9

    PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Freedman DS et al (2002) Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics 110(4):e43

    PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Adair LS, Gordon-Larsen P (2001) Maturational timing and overweight prevalence in US adolescent girls. Am J Public Health 91(4):642

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Ogland B et al (2011) Pubertal development in daughters of women with pre-eclampsia. Arch Dis Child 96(8):740

    PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    Ibáñez L, de Zegher F (2006) Puberty after prenatal growth restraint. Horm Res 65(Suppl 3):112–112

    PubMed  PubMed Central  Google Scholar 

  8. 8.

    Elks CE et al (2010) Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 42(12):1077–1085

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Sulem P et al (2009) Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat Genet 41(6):734–738

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Day FR et al (2017) Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet 49(6):834–841

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Biro FM et al (2013) Onset of breast development in a longitudinal cohort. Pediatrics 132(6):1019

    PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Yang L et al (2017) Adiposity in relation to age at menarche and other reproductive factors among 300 000 Chinese women: findings from China Kadoorie Biobank study. Int J Epidemiol 46(2):502

    PubMed  PubMed Central  Google Scholar 

  13. 13.

    Vandenbergh JG (1974) Social determinants of the onset of puberty in rodents. J Sex Res 10(3):181–193

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    Ellis BJ, Garber J (2000) Psychosocial antecedents of variation in girls’ pubertal timing: maternal depression, stepfather presence, and marital and family stress. Child Dev 71(2):485–501

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Boynton-Jarrett R, Harville EW (2012) A prospective study of childhood social hardships and age at menarche. Ann Epidemiol 22(10):731–737

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Sun Y et al (2017) Childhood social disadvantage and pubertal timing: a national birth cohort from Australia. Pediatrics 139(6):e2016409

    Article  Google Scholar 

  17. 17.

    Mandel D, Zimlichman E, Mimouni FB, Grotto I, Kreiss Y (2004) Age at menarche and body mass index: a population study. J Pediatr Endocrinol Metab 17(11):1507–1510

    PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Euling SY, Herman-Giddens ME, Lee PA et al (2008) Examination of US puberty timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 121(3):172–191

    Article  Google Scholar 

  19. 19.

    Sanyal S, Ray S (2012) Variation in the menstrual characteristics in adolescents of West Bengal. Singapore Med J 49(7):542–550

    Google Scholar 

  20. 20.

    Adgent MA et al (2012) Early-life soy exposure and age at menarche. Paediatr Perinat Epidemiol 26:163–175

    PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Teilmann G, Petersen JH, Gormsen M et al (2009) Early puberty in internationally adopted girls: hormonal and clinical markers of puberty in 276 girls examined biannually over two years. Horm Res 72(4):236–246

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Bourguignon P. [Hrsg.]Management of precocious puberty: food for thought. J Sandoz Satellite Symposium at the 53rd ESPE Meeting. Dublin : s.n., 2014. Precocious puberty: diagnosis and management—to treat or not to treat.

  23. 23.

    Aksglaede L et al (2009) Recent decline in Age at breast development: the copenhagen puberty study. Pediatrics 123:e932–e939

    PubMed  Article  PubMed Central  Google Scholar 

  24. 24.

    Marshall WA et al (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Cabrera SM et al (2014) Age of thelarche and menarche in contemporary US females: a cross-sectional analysis. J Pediatr Endocrinol Metab 27:47–51

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123(4):e752–e762

    PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    de Vries L et al (2010) Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty. J Pediatr 156(3):466–471

    PubMed  Article  PubMed Central  Google Scholar 

  28. 28.

    Pin L, Li Y, Chung-Lin Y (2014) Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty. Medicine 93(27):e260

    Article  CAS  Google Scholar 

  29. 29.

    Golden NH, Lanzkowsky L et al (2002) The effect of oestrogen-progestin treatment on bone mineral density in anorexis nervosa. J Pediatr Adolesc Gynaecol 15:135–143

    Article  Google Scholar 

  30. 30.

    Persani L (2012) Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 97(9):3068

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  31. 31.

    Daschner M, Philippin B et al (2002) Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Kidney Int 62:1582–1590

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Eldar-Geva T, Hirsch HJ et al (2013) Management of hypogonadism in adolescent girls and adult women with Prader-Willi syndrome. Am J Med Genet A 161(12):3030–3034

    CAS  Article  Google Scholar 

  33. 33.

    Mattle V, Dörr HG et al (2005) Diagnostik und Therapie der Pubertas tarda bei der Frau. J Reproduktionsmed Endokrinol 2(3):163–172

    Google Scholar 

  34. 34.

    Harrington J, Palmert MR (2012) Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. J Clin Endocrinol Metab 97(9):3056–3067

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  35. 35.

    Garnett MR, Puget S et al (2007) Craniopharyngeoma. Orphanet J Rare Dis 2:18

    PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Bauchet L, Rigau V et al (2009) Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol 92(1):87–98

    PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Packer RJ, Cohen BH, Cooney K (2000) Intracranial germ cell tumors. Oncologist 5:312–320

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  38. 38.

    Ranke MB, Dörr HG (2008) Hypogonadismus in der Adoleszenz. Verlag Wissenschaftliche Scripten, Auerbach, S 107–113

    Google Scholar 

  39. 39.

    Keil MF, Stratakis A (2008) Pituitary tumors in childhood: an update in their diagnosis, treatment and molecular genetics. Expert Rev Neurother 8(4):563–574

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Fideleff HL, Boquete HR et al (2009) Prolactinoma in children and adolescents. Horm Res 72:197–205

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  41. 41.

    Latronico AC, Arnhold IJ (2012) Inactivating mutations of the human luteinizing hormone receptor in both sexes. Semin Reprod Med 30(5):382–386

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    Forges T, Monnier-Barbarino P et al (2006) Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update 12(5):573–584

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Persani L, Rosetti R, Cacciatore C (2010) Genes involved in human premature ovarian failure. J Mol Endokrinol 45:257–279

    CAS  Article  Google Scholar 

  44. 44.

    Dixit H et al (2010) Genes governing premature ovarian failure. Reprod Biomed Online 20:724–740

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  45. 45.

    Zhong QBS, Layman LC (2012) Genetic considerations in the patient with Turner Syndrome—45X with or without mosaicism. Fertil Steril 98(4):775–779

    PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Ranke MB, Dörr HG (2008) Hypogonadismus in der Adoleszenz – Therapien zur Optimierung von Feminisierung, Maskulinisierung und Wachstum. Verlag Wissenschaftliche Scripten, Auerbach, S 115–124

    Google Scholar 

  47. 47.

    Gonzales L, Feldman Witchel S (2012) The patient with turner syndrome: puberty and medical management concerns. Fertil Steril 98(4):780–786

  48. 48.

    Brougham MFH, Crofton PM et al (2012) Anti-Müllerian hormone is a marker of Gonadotoxicity in pre- and Postpubertal girls treated for cancer: a prospective study. J Clin Endocrinol Metab 97(6):2059–2067

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  49. 49.

    Binder G, Schweizer R, Haber P, Blumenstock G, Braun R (2015) Accuracy of endocrine tests for detecting hypogonadotropic hypogonadism in girls. J Pediatr 167(3):674–678

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  50. 50.

    Nitsche E (2016) Pubertas tarda. Frauenheilkd Up2date 10(2):119–133

    Article  Google Scholar 

  51. 51.

    Prader A (1975) Delayed adolescence. Clin Endocrinol Metab 4:143–150

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  52. 52.

    Eichenberg C, Brähler E (2007) „Nothing tastes as good as thin feels…“ – Einschätzungen zur Pro-Anorexia-Bewegung im Internet. Psychother Psychosom Med Psychol 57:269–270

    PubMed  Article  PubMed Central  Google Scholar 

  53. 53.

    Ezri J, Marques-Vidal P, Nydegger A (2012) Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease. Digestion 85:308–319

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  54. 54.

    Skordis N, Kyriakou A (2011) The multifactorial origin of growth failure in thalassaemia. Pediatr Endocrinol Rev 8(Suppl 2):271–277

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Trarbach EB, Silveira LG, Latronico LC (2007) Genetic Insights into human isolated gonadotropin deficiency. Pituitary 10:381–391

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  56. 56.

    Kaspers S, Richter-Unruh A et al (2004) Buserelin testing in 70 adolescents with delayed puberty. Horm Res 62(Suppl 2):80

    Google Scholar 

  57. 57.

    Taher AT, Viprakasit V et al (2013) Treating iron overload in patients with non-transfusion-dependent Thalassemia. Am J Hematol 88(5):409–415

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  58. 58.

    Zemel BS, Kawchak DA et al (2007) Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res 61:607–613

    PubMed  Article  PubMed Central  Google Scholar 

  59. 59.

    Paris F, Philibert P et al (2007) Primary Amenorrhoea in a 46XY adolescent girl with partial gonadal dysgenesis: identification of a new SRY gene mutation. Fertil Steril 88:e21–e25

    Article  Google Scholar 

  60. 60.

    Gubbels CS, Kuppens SM et al (2006) Pregnancy in classic galactosemia despite undetectable anti-Müllerian hormone. Fertil Steril 19(4):1293.e13–1293.e16

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Esther M. Nitsche.

Ethics declarations

Interessenkonflikt

E.M. Nitsche gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Aktualisierte Version der Originalpublikation von Nitsche EM (2017) Pubertätsstörungen beim Mädchen. Gynäkologe 50:867–878. https://doi.org/10.1007/s00129-017-4137-9

figureqr

QR-Code scannen & Beitrag online lesen

Redaktion

Gisela Gille, Lüneburg

Katrin Schaudig, Hamburg

Anneliese Schwenkhagen, Hamburg

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nitsche, E.M. Pubertät – Normalität, Normvarianten und Abweichungen. Gynäkologe 54, 626–639 (2021). https://doi.org/10.1007/s00129-021-04852-y

Download citation

Schlüsselwörter

  • Vorzeitige Pubertät
  • Verspätete Pubertät
  • Störungen der körperlichen Entwicklung
  • Pubertätsstörung
  • Sexuelle Reifung

Keywords

  • Precocious puberty
  • Delayed puberty
  • Impaired physical development
  • Disorders of puberty
  • Sexual maturation